Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

Authors:
  • OIOn behalf of the SBC/EPICURO Study Investigators
    On behalf of the SBC/EPICURO Study Investigators

Abstract
We adapted Bayesian statistical learning strategies to the prognosis field to investigate if genome-wide common SNP improve the prediction ability of clinico-pathological prognosticators and applied it to non-muscle invasive bladder cancer (NMIBC) patients. Adapted Bayesian sequential threshold models in combination with LASSO were applied to consider the time-to-event and the censoring nature of data. We studied 822 NMIBC patients followed-up >10 years. The study outcomes were time-to-first-recurrence and time-to-progression. The predictive ability of the models including up to 171,304 SNP and/or 6 clinico-pathological prognosticators was evaluated using AUC-ROC and determination coefficient. Clinico-pathological prognosticators explained a larger proportion of the time-to-first-recurrence (3.1 %) and time-to-progression (5.4 %) phenotypic variances than SNPs (1 and 0.01 %, respectively). Adding SNPs to the clinico-pathological-parameters model slightly improved the prediction of time-to-first-recurrence (up to 4 %). The prediction of time-to-progression using both clinico-pathological prognosticators and SNP did not improve. Heritability (ĥ 2) of both outcomes was <1 % in NMIBC. We adapted a Bayesian statistical learning method to deal with a large number of parameters in prognostic studies. Common SNPs showed a limited role in predicting NMIBC outcomes yielding a very low heritability for both outcomes. We report for the first time a heritability estimate for a disease outcome. Our method can be extended to other disease models.
Funding Information
  • Instituto de Salud Carlos III (#PI06-1614, #PI00-0745)
  • Fundación Científica Asociación Española Contra el Cáncer
  • Seventh Framework Programme (EU-7FP-HEALTH-TransBioBC #601933, EU-FP7-HEALTH-F2-2008-201663-UROMOL)
  • European Urological Scholarship Program for Research (S-01-2013)
  • Red Temática de Investigación Cooperativa en Cáncer ((#RD12/0036/0050)
  • Instituto de Saludo Carlos III (#PI05-1436)
  • Intramural Research Program, Division of Cancer Epidemiology and Genetics (NCI NO2-CP-11015)